Comparison of the effectiveness of solid nutrient medium in the in vitro cultivation of Neisseria gonorrhoeae isolates

Background. Neisseria gonorrhoeae is a facultatively anaerobic microorganism which is extremely demanding to the composition of a nutrient media and cultivation conditions. In a situation of the increasing shortage and cost of foreign components for the preparation of solid nutrient media, it is important to study the possibility of growing hard-to-cultivate microorganisms on domestically produced nutrient media.

The aim of the study. To evaluate the growth of gonococcus colonies on two types of solid nutrient media – chocolate agar with growth and selective additives prepared using imported reagents and chocolate agar with growth additives manufactured by “Gem LTD” (Moscow, Russian Federation).

Materials and methods. А reference strain of N. gonorrhoeae NCTC 12700/ ATCC 49226 and two types of chocolate agar (the first one – prepared in the State Scientific Center of Dermatovenerology and Cosmetology using imported components and the other one – from the domestic manufacturer “Gem LTD”) were used in the research.

Results. The equivalence of the growth properties of both studied types of nutrient media when cultivating pure gonococcus was revealed.

Conclusions. Ready-to-use chocolate agar with growth additives produced by “Gem LTD” can be successfully used in the laboratory for the cultivation of N. gonorrhoeae pure culture. Primary isolation of N. gonorrhoeae strains from clinical material is more appropriate to carry out on a medium that suppresses the growth of foreign microflora due to the inclusion of antibiotic additive. The organization of production of domestic bacteriological media for microorganisms with high nutrient requirements reduces the dependence of domestic microbiology on import and ensures their rapid delivery to laboratories.

1. World Health Organization. Global health sector strategy on sexually transmitted infections, 2016–2021. URL: https://www.who.int/publications/i/item/WHO-RHR-16.09 [date of access: 11.04.2023].

2. WHO publishes list of bacteria for which new antibiotics are urgently needed. 27.02.2017. URL: https://www.who.int/ru/news/item/27-02-2017-who-publishes-list-of-bacteria-for-whichnew-antibiotics-are-urgently-needed/ [date of access: 11.04.2023].

3. Kubanov AA, Solomka VS, Rakhmatulina MR, Deryabin DG. Antimicrobial resistance of Neisseria gonorrhoeae and gonococcal infection therapy: Yesterday, today, tomorrow. Vestnik dermatologii i venerologii. 2022; 98(3): 15-23. (In Russ.). doi: 10.25208/vdv1317

4. All-Russian Public Organization “Russian Society of Dermatovenereologists and Cosmetologists”, Russian Society of Obstetricians and Gynecologists. Gonococcal infection: Clinical guidelines. 2021. (In Russ.). URL: https://legalacts.ru/doc/klinicheskie-rekomendatsii-gonokokkovaja-infektsija-utvminzdravom-rossii/ [date of access: 11.05.2023].

5. Radcliffe K. European standards for diagnosis and treatment of sexually transmitted diseases. Moscow: Meditsinskaya literatura; 2021. (In Russ.).

6. Mirrett S, Reller LB, Knapp JS. Neisseria gonorrhoeae strains inhibited by vancomycin in selective media and correlation with auxotype. J Clin Microbiol. 1981; 14: 94-99. doi: 10.1128/jcm.14.1.94-99.1981

7. Wi T, Lahra MM, Ndowa F, Bala M, Dillon J-AR, RamonPardo P, et al. Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLoS Med. 2017; 14(7): e1002344. doi: 10.1371/journal.pmed.1002344

8. Kubanova AA, Kubanov AA, Frigo NV, Polevshchikova SA, Solomka VS, Lesnaya IN, et al. Standard operating procedures for species identification of the gonorrhea pathogen. Collection of standard operating procedures (SOP No. GON 003/04; SOP No. GON 004/04; SOP No. GON 005/04). Moscow: OOO «DEKSPRESS»; 2008. (In Russ.). URL: https://www.cnikvi.ru/upload/files/369_SOP_ident_gonorei.pdf [date of access: 11.04.2023].

9. Dense nutrient medium for the isolation of fastidious microorganisms, ready to use, chocolate agar with growth additives according to TU 9385-003-16665457-2013: Registration certificate for a medical device No. RZN 2014/2242 d.d. from 31.12.2014. (In Russ.). URL: https://nevacert.ru/reestry/med-reestr/rzn-2014-2242-2796 [date of access: 11.04.2023].

10. CLSI methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard; 9th ed. Wayne, PA; 2014.